Frontlight ResearchEarly access
CompletedNo phase
Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy
Key facts
- Who runs it
- Services Hospital, Lahore
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 136 people enrolled
- Started
- 10 Jan 2022
- Ended
- 20 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Intraoperative topical methylene blue spray
- Conventional Dissection
- Record updated
- 9 February 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- benign multinodular goiter scheduled for thyroidectomy
Who cannot take part
- Recurrent/metastatic disease
- Methylene blue allergy
- Hepatic/renal impairment
- Preoperative vocal cord dysfunction
- Coagulopathy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial aims to evaluate the efficacy of intraoperative methylene blue (MB) spray in improving the identification and preservation of the recurrent laryngeal nerve (RLN) and parathyroid glands (PGs) during thyroidectomy. The study compares outcomes between patients receiving topical MB spray and those undergoing conventional visual dissection alone. Primary outcomes include the incidence of RLN injury and postoperative serum calcium levels.
The 2 groups in the trial
- Methylene Blue labellingTreatment being tested
Treatment: Intraoperative topical methylene blue spray
- Conventional DissectionExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy: A Randomized Controlled Trial
- Record updated
- 9 February 2026